Effects of Home-based Pulmonary Rehabilitation in Patients With Severe or Very Severe Chronic Obstructive Pulmonary Disease (COPD)

January 30, 2012 updated by: Marta Lazzeri, Associazione Riabilitatori Insufficienza Respiratoria

Randomised Controlled Trial on the Effects of Home-based Pulmonary Rehabilitation in Patients With Severe or Very Severe COPD

This study will investigate if adding a domiciliary respiratory physiotherapy treatment to standard care in patients with chronic obstructive pulmonary disease (COPD) can improve physical function (walking test) and quality of life.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

182

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Varese
      • Busto Arsizio, Varese, Italy
        • Recruiting
        • Unità di pneunologia, Ospedale di Busto Arsizio

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Severe COPD (FEV1/FVC < 70% and FEV1 < 50% pred.) associated to hypoxaemic chronic respiratory insufficiency (PaO2 < 60mmHg) or
  • Very severe COPD (FEV1/FVC < 70% and FEV1 < 30% pred.)

With the following characteristics:

  • no signs of lung restriction (TLC≥80%)
  • clinically stable for at least the last four weeks
  • MRC ≥ 2
  • no participation to PR programmes in the last year

FEV1= Forced expiratory volume in the 1st second FVC= Forced vital capacity TLC= Total Lung Capacity PaO2= Partial pressure of arterial oxygen

Exclusion Criteria:

  • - Muscular-skeletal impairment that could limit the patient's participation to the exercise programme;
  • Cognitive impairment that could limit the patient's participation to the activities of education and exercise, as assessed by the Mini Mental State (MMS) test <26;
  • Malignancies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Care

Drugs for COPD (as prescribed), oxygen therapy if needed*, check-up by the general practitioner and/or respirologist as usual.

Educational leaflet regarding optimization of oxygen therapy and drugs; Benefits of physical activity and proposal of a programme of exercise training; Energy conservation techniques; Nutritional counselling; Activity of daily Living (ADL) diary; Prevention and management of acute exacerbation

Monthly phone call with the aim of verifying:

  • the patients' clinical conditions;
  • the patient's adherence to the pharmacological treatments prescribed
  • the patient's compliance in filling out the clinical diary and the ADL diary
As describe in the standard care arm
Experimental: domiciliary rehabilitation

Same as the standard care group plus 10 (ten) home-based visits supervised by a specifically trained respiratory therapist (education+exercise training) Autonomous home-based programme: The patients will be given instructions and training in order to continue the exercise training programme on the days the respiratory therapist is not visiting them.

Counselling addressed at the outdoor activities.

a respiratory rehabilitation programme at the patient home

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
meters as per walking test performance
Time Frame: 8 weeks
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: 6 months
6 months
Quality of life
Time Frame: 12 months
12 months
Quality of life
Time Frame: 8 weeks
8 weeks
Bode index
Time Frame: 8 weeks
This index is a combination of walking test result, Body Mass Index and respiratory measurement
8 weeks
dyspnea
Time Frame: 8 weeks
8 weeks
relapses
Time Frame: 8 weeks
8 weeks
services utilization
Time Frame: 8 weeks
visits to the GP or Pneumologist that were not planned, hospital visits (emergency room )
8 weeks
meters as per walking test performance
Time Frame: 6 months
6 months
Bode index
Time Frame: 6 months
This index is a combination of walking test result, Body Mass Index and respiratory measurement
6 months
dyspnea
Time Frame: 6 months
6 months
relapses
Time Frame: 6 months
6 months
services utilization
Time Frame: 6 months
visits to the GP or Pneumologist that were not planned, hospital visits (emergency room )
6 months
meters as per walking test performance
Time Frame: 12 months
12 months
Bode index
Time Frame: 12 months
This index is a combination of walking test result, Body Mass Index and respiratory measurement
12 months
dyspnea
Time Frame: 12 months
12 months
relapses
Time Frame: 12 months
12 months
services utilization
Time Frame: 12 months
visits to the GP or Pneumologist that were not planned, hospital visits (emergency room )
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Anticipated)

September 1, 2012

Study Completion (Anticipated)

September 1, 2012

Study Registration Dates

First Submitted

September 7, 2010

First Submitted That Met QC Criteria

September 9, 2010

First Posted (Estimate)

September 10, 2010

Study Record Updates

Last Update Posted (Estimate)

January 31, 2012

Last Update Submitted That Met QC Criteria

January 30, 2012

Last Verified

January 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Standard Care

3
Subscribe